15 results
6-K
EX-99.1
IPHA
Innate Pharma
13 Nov 20
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome
6:30am
and debilitating pruritus (chronic itchy skin). Despite recent advancements, SS is associated with a high relapse rate with currently available
6-K
EX-99.1
djlb0pxdlkdo
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
20-F
0iu8549lr
24 Apr 20
Annual report (foreign)
10:43am
424B4
4sjztcl4dhbusmrrw
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
8q5 f841h
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
cl6h 4yzxzyrtzw
20 Sep 19
Registration statement (foreign)
4:08pm
F-1
EX-10.1
irnm9kufsfr9z0gmmnh
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
EX-10.1
ye5lnh
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
laufich2wc cyngy
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
r1sfnluw
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
5nzeyeud97 i2ghf4
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next